Favezelimab (Anti-LAG3 / CD223)
A2994
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameFavezelimab (Anti-LAG3 / CD223)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionFavezelimab (Anti-LAG3 / CD223) is a humanized monoclonal antibody that targets LAG-3. It has the potential for colorectal cancer (CRC) research. MW :145.98 KD.
- Storage Instruction-20°C
- UNSPSC12352203